title: Difficult-to-treat Gram-negative bone and joint infections: efficacy and safety of prolonged intravenous colistin.
authors.forename: Florent
authors.initials: F
authors.lastname: Valour
authors.forename: Hervé
authors.initials: H
authors.lastname: Dutronc
authors.forename: Aurélien
authors.initials: A
authors.lastname: Dinh
authors.forename: Céline
authors.initials: C
authors.lastname: Cazorla
authors.forename: Patricia
authors.initials: P
authors.lastname: Pavèse
authors.forename: Olivier
authors.initials: O
authors.lastname: Lesens
authors.forename: Ilker
authors.initials: I
authors.lastname: Uçkay
authors.forename: Christian
authors.initials: C
authors.lastname: Chidiac
authors.forename: Tristan
authors.initials: T
authors.lastname: Ferry
mesh_terms: D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D015331:Cohort Studies; D003091:Colistin / Q000008:administration & dosage* / Q000009:adverse effects*; D024901:Drug Resistance, Multiple, Bacterial; D064420:Drug-Related Side Effects and Adverse Reactions / Q000453:epidemiology; D005260:Female; D005602:France; D006090:Gram-Negative Bacteria / Q000187:drug effects / Q000302:isolation & purification; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D010003:Osteoarthritis / Q000188:drug therapy* / Q000382:microbiology; D012189:Retrospective Studies; D013557:Switzerland; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D003091:Colistin